HL7 Terminology (THO)
3.1.5 - Continuous Process Integration (ci build) International flag

HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This is not an authorized publication; it is the continuous build for version 3.1.5). This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

ValueSet: MedicationGeneralizationRoleType

Official URL: http://terminology.hl7.org/ValueSet/v3-MedicationGeneralizationRoleType Version: 2.0.0
Active as of 2014-03-26 Computable Name: MedicationGeneralizationRoleType
Other Identifiers: : urn:oid:2.16.840.1.113883.1.11.19720

Identifies the specific hierarchical relationship between the playing and scoping medications.

Examples: Generic, Generic Formulation, Therapeutic Class, etc.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

 

Expansion

This value set contains 6 concepts

Expansion based on RoleCode v2.2.0 (CodeSystem)

All codes in this table are from the system http://terminology.hl7.org/CodeSystem/v3-RoleCode

LevelCodeDisplayDefinition
1  _MedicationGeneralizationRoleTypeMedicationGeneralizationRoleTypeIdentifies the specific hierarchical relationship between the playing and scoping medications. *Examples:* Generic, Generic Formulation, Therapeutic Class, etc.
2    DCtherapeutic class**Description:**A categorization of medicinal products by their therapeutic properties and/or main therapeutic use.
2    GDgeneric drugRelates a manufactured drug product to the non-proprietary (generic) representation of its ingredients independent of strength, and form. The scoping entity identifies a unique combination of medicine ingredients; sometimes referred to as "ingredient set".
3      GDFgeneric drug formRelates a manufactured drug product to the non-proprietary (generic) representation of its ingredients and dose form, independent of strength of the ingredients. The scoping entity identifies a unique combination of medicine ingredients in a specific dose form.
3      GDSgeneric drug strengthRelates a manufactured drug product to the non-proprietary (generic) representation of is ingredients with their strength. The scoping entity identifies a unique combination of medicine ingredients with their strength.
3      GDSFgeneric drug strength formRelates a manufactured drug product to the non-proprietary (generic) representation of its ingredients with their strength in a specific dose form. The scoping entity identifies a unique combination of medicine ingredients with their strength in a single dose form.
2    MGDSFmanufactured drug strength formRelates a manufactured drug product to the non-proprietary (generic) representation of its ingredients with their strength in a specific dose form. The scoping entity identifies a unique combination of medicine ingredients with their strength in a single dose form.

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code

History

DateActionCustodianAuthorComment
2020-05-06reviseVocabulary WGTed KleinMigrated to the UTG maintenance environment and publishing tooling.